Patents by Inventor Rolf-Markus Szeimies

Rolf-Markus Szeimies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dermal application system for aminolevulinic acid-derivatives
    Patent number: 8465762
    Abstract: The invention relates to a dermal application system for aminolevulinic acid-derivatives, i.e. a pressure-sensitive matrix system containing a crystalline aminolevulinic acid derivative.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: June 18, 2013
    Assignee: Photonamic GmbH & Co. KG
    Inventors: Geoffrey Lee, Rolf-Markus Szeimies, Ulrich Kosciessa
  • Dermal application system for aminolaevulinic acid
    Patent number: 7951395
    Abstract: The invention relates to a dermal for aminolaevulinic acid, wherein a self-adhesive matrix system is used containing crystalline aminolaevulinic acids.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: May 31, 2011
    Assignee: Photonamic GmbH & Co. KG
    Inventors: Geoffrey Lee, Rolf-Markus Szeimies
  • Dermal application system for aminolevulinic acid-derivatives
    Publication number: 20060018956
    Abstract: The invention relates to a dermal application system for aminolevulinic acid-derivatives, i.e. a pressure-sensitive matrix system containing a crystalline aminolevulinic acid derivative.
    Type: Application
    Filed: January 16, 2003
    Publication date: January 26, 2006
    Inventors: Geoffrey Lee, Rolf-Markus Szeimies, Ulrich Kosciessa
  • Dermal for amino laevulinic acid
    Publication number: 20050013852
    Abstract: The invention relates to a dermal for amino laevulinic acid, wherein a self-adhesive matrix system is used containing crystalline amino laevulinic acids ran release
    Type: Application
    Filed: July 13, 2001
    Publication date: January 20, 2005
    Inventors: Geoffrey Lee, Rolf-Markus Szeimies
  • Device for treating growing, dilated or malformed blood vessels and method for treating biological material
    Patent number: 6491715
    Abstract: In a device for treating blood vessels with a laser, the laser provides a beam in a wavelength range from 750 to 850 nm, preferably 805 nm. The device has a measuring unit which measures the concentration of a chromophore (preferably indocyanine green) administered to the patient in the patient's blood vessels. The device further comprises a control unit which controls the power of the laser in a contrary sense to the measured concentration.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: December 10, 2002
    Assignee: Pulsion Medical Systems AG
    Inventors: Christoph Abels, Rolf-Markus Szeimies